Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 179

2.

Receptor type I and type II binding regions and the peptidyl-prolyl isomerase site of cyclophilin B are required for enhancement of T-lymphocyte adhesion to fibronectin.

Carpentier M, Allain F, Slomianny MC, Durieux S, Vanpouille C, Haendler B, Spik G.

Biochemistry. 2002 Apr 23;41(16):5222-9.

PMID:
11955071
3.

Interaction with glycosaminoglycans is required for cyclophilin B to trigger integrin-mediated adhesion of peripheral blood T lymphocytes to extracellular matrix.

Allain F, Vanpouille C, Carpentier M, Slomianny MC, Durieux S, Spik G.

Proc Natl Acad Sci U S A. 2002 Mar 5;99(5):2714-9. Epub 2002 Feb 26.

4.

The binding of lactoferrin to glycosaminoglycans on enterocyte-like HT29-18-C1 cells is mediated through basic residues located in the N-terminus.

El Yazidi-Belkoura I, Legrand D, Nuijens J, Slomianny MC, van Berkel P, Spik G.

Biochim Biophys Acta. 2001 Dec 19;1568(3):197-204.

PMID:
11786226
5.

Delineation of the calcineurin-interacting region of cyclophilin B.

Carpentier M, Allain F, Haendler B, Slomianny MC, Spik G.

Protein Sci. 2000 Dec;9(12):2386-93.

7.

Lactoferrin upregulates the expression of CD4 antigen through the stimulation of the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line.

Dhennin-Duthille I, Masson M, Damiens E, Fillebeen C, Spik G, Mazurier J.

J Cell Biochem. 2000 Sep 14;79(4):583-93.

PMID:
10996849
8.

Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.

Fillebeen C, Mitchell V, Dexter D, Benaissa M, Beauvillain J, Spik G, Pierce A.

Brain Res Mol Brain Res. 1999 Oct 1;72(2):183-94.

PMID:
10529477
9.

Regulatory effects of lactoferrin and lipopolysaccharide on LFA-1 expression on human peripheral blood mononuclear cells.

Zimecki M, Miedzybrodzki R, Mazurier J, Spik G.

Arch Immunol Ther Exp (Warsz). 1999;47(4):257-64.

PMID:
10483875
10.

Cyclophilin B binding to platelets supports calcium-dependent adhesion to collagen.

Allain F, Durieux S, Denys A, Carpentier M, Spik G.

Blood. 1999 Aug 1;94(3):976-83.

PMID:
10419889
11.

Lactoferrin inhibits G1 cyclin-dependent kinases during growth arrest of human breast carcinoma cells.

Damiens E, El Yazidi I, Mazurier J, Duthille I, Spik G, Boilly-Marer Y.

J Cell Biochem. 1999 Sep 1;74(3):486-98.

PMID:
10412049
12.

Receptor-mediated transcytosis of cyclophilin B through the blood-brain barrier.

Carpentier M, Descamps L, Allain F, Denys A, Durieux S, Fenart L, Kieda C, Cecchelli R, Spik G.

J Neurochem. 1999 Jul;73(1):260-70.

13.

Lactoferrin: a multifunctional glycoprotein involved in the modulation of the inflammatory process.

Baveye S, Elass E, Mazurier J, Spik G, Legrand D.

Clin Chem Lab Med. 1999 Mar;37(3):281-6. Review.

PMID:
10353473
14.

Porins OmpC and PhoE of Escherichia coli as specific cell-surface targets of human lactoferrin. Binding characteristics and biological effects.

Sallmann FR, Baveye-Descamps S, Pattus F, Salmon V, Branza N, Spik G, Legrand D.

J Biol Chem. 1999 Jun 4;274(23):16107-14.

15.

Two distinct regions of cyclophilin B are involved in the recognition of a functional receptor and of glycosaminoglycans on T lymphocytes.

Carpentier M, Allain F, Haendler B, Denys A, Mariller C, Benaïssa M, Spik G.

J Biol Chem. 1999 Apr 16;274(16):10990-8.

16.

Receptor-mediated transcytosis of lactoferrin through the blood-brain barrier.

Fillebeen C, Descamps L, Dehouck MP, Fenart L, Benaïssa M, Spik G, Cecchelli R, Pierce A.

J Biol Chem. 1999 Mar 12;274(11):7011-7.

17.

Role of heparan sulphate proteoglycans in the regulation of human lactoferrin binding and activity in the MDA-MB-231 breast cancer cell line.

Damiens E, El Yazidi I, Mazurier J, Elass-Rochard E, Duthille I, Spik G, Boilly-Marer Y.

Eur J Cell Biol. 1998 Dec;77(4):344-51.

PMID:
9930659
18.
19.

Lactoferrin. Its role in maturation and function of cells of the immune system and protection against shock in mice.

Zimecki M, Kapp J, Machnicki M, Zagulski T, Wlaszczyk A, Kübler A, Mazurier J, Spik G.

Adv Exp Med Biol. 1998;443:331-6. No abstract available.

PMID:
9781377
20.

Lactoferrin is synthesized by mouse brain tissue and its expression is enhanced after MPTP treatment.

Fillebeen C, Dexter D, Mitchell V, Benaissa M, Beauvillain JC, Spik G, Pierce A.

Adv Exp Med Biol. 1998;443:293-300.

PMID:
9781372
21.

Lactoferrin stimulates the mitogen-activated protein kinase in the human lymphoblastic T Jurkat cell line.

Duthille I, Masson M, Spik G, Mazurier J.

Adv Exp Med Biol. 1998;443:257-60. No abstract available.

PMID:
9781367
22.

Role of the first N-terminal basic cluster of human lactoferrin (R2R3R4R5) in the interactions with the Jurkat human lymphoblastic T-cells.

Legrand D, van Berkel PH, Salmon V, van Veen HA, Slomianny MC, Nuijens JH, Spik G.

Adv Exp Med Biol. 1998;443:49-55.

PMID:
9781342
23.

Immunoregulatory effects of a nutritional preparation containing bovine lactoferrin taken orally by healthy individuals.

Zimecki M, Właszczyk A, Cheneau P, Brunel AS, Mazurier J, Spik G, Kübler A.

Arch Immunol Ther Exp (Warsz). 1998;46(4):231-40.

PMID:
9779289
24.

Production of human lactoferrin in transgenic tobacco plants.

Salmon V, Legrand D, Slomianny MC, el Yazidi I, Spik G, Gruber V, Bournat P, Olagnier B, Mison D, Theisen M, Mérot B.

Protein Expr Purif. 1998 Jun;13(1):127-35.

PMID:
9631525
25.

Structure of the O-glycopeptides isolated from bovine milk component PP3.

Coddeville B, Girardet JM, Plancke Y, Campagna S, Linden G, Spik G.

Glycoconj J. 1998 Apr;15(4):371-8.

PMID:
9613824
26.

Effects of human lactoferrin on NK cell cytotoxicity against haematopoietic and epithelial tumour cells.

Damiens E, Mazurier J, el Yazidi I, Masson M, Duthille I, Spik G, Boilly-Marer Y.

Biochim Biophys Acta. 1998 Apr 24;1402(3):277-87.

27.

Enhancing the effect of secreted cyclophilin B on immunosuppressive activity of cyclosporine.

Denys A, Allain F, Masy E, Dessaint JP, Spik G.

Transplantation. 1998 Apr 27;65(8):1076-84.

PMID:
9583869
28.

The N-terminal Arg2, Arg3 and Arg4 of human lactoferrin interact with sulphated molecules but not with the receptor present on Jurkat human lymphoblastic T-cells.

Legrand D, van Berkel PH, Salmon V, van Veen HA, Slomianny MC, Nuijens JH, Spik G.

Biochem J. 1997 Nov 1;327 ( Pt 3):841-6.

29.
30.

Lactoferrin inhibits the endotoxin interaction with CD14 by competition with the lipopolysaccharide-binding protein.

Elass-Rochard E, Legrand D, Salmon V, Roseanu A, Trif M, Tobias PS, Mazurier J, Spik G.

Infect Immun. 1998 Feb;66(2):486-91.

31.

Distribution of cyclophilin B-binding sites in the subsets of human peripheral blood lymphocytes.

Denys A, Allain F, Foxwell B, Spik G.

Immunology. 1997 Aug;91(4):609-17.

32.

Characterization of human lactoferrin produced in the baculovirus expression system.

Salmon V, Legrand D, Georges B, Slomianny MC, Coddeville B, Spik G.

Protein Expr Purif. 1997 Mar;9(2):203-10.

PMID:
9056485
33.

Effect of lactoferrin on proliferation and differentiation of the Jurkat human lymphoblastic T cell line.

Bi BY, Lefebvre AM, Duś D, Spik G, Mazurier J.

Arch Immunol Ther Exp (Warsz). 1997;45(4):315-20.

PMID:
9523007
34.

Involvement of the N-terminal part of cyclophilin B in the interaction with specific Jurkat T-cell binding sites.

Mariller C, Haendler B, Allain F, Denys A, Spik G.

Biochem J. 1996 Jul 15;317 ( Pt 2):571-6.

36.

Solution structure of bovine angiogenin by 1H nuclear magnetic resonance spectroscopy.

Lequin O, Albaret C, Bontems F, Spik G, Lallemand JY.

Biochemistry. 1996 Jul 9;35(27):8870-80.

PMID:
8688423
37.

Evidence that human milk isolated cyclophilin B corresponds to a truncated form.

Mariller C, Allain F, Kouach M, Spik G.

Biochim Biophys Acta. 1996 Mar 7;1293(1):31-8.

PMID:
8652625
38.

Internalization of human lactoferrin by the Jurkat human lymphoblastic T-cell line.

Bi BY, Liu JL, Legrand D, Roche AC, Capron M, Spik G, Mazurier J.

Eur J Cell Biol. 1996 Mar;69(3):288-96.

PMID:
8900493
39.

Lactoferrin inhibits proliferative response and cytokine production of TH1 but not TH2 cell lines.

Zimecki M, Mazurier J, Spik G, Kapp JA.

Arch Immunol Ther Exp (Warsz). 1996;44(1):51-6.

PMID:
8874770
40.

Cellular distribution of the iron-binding protein lactotransferrin in the mesencephalon of Parkinson's disease cases.

Leveugle B, Faucheux BA, Bouras C, Nillesse N, Spik G, Hirsch EC, Agid Y, Hof PR.

Acta Neuropathol. 1996;91(6):566-72.

PMID:
8781654
41.

Structure of glycopeptides isolated from bovine milk component PP3.

Girardet JM, Coddeville B, Plancke Y, Strecker G, Campagna S, Spik G, Linden G.

Eur J Biochem. 1995 Dec 15;234(3):939-46.

42.

Lactoferrin-lipopolysaccharide interaction: involvement of the 28-34 loop region of human lactoferrin in the high-affinity binding to Escherichia coli 055B5 lipopolysaccharide.

Elass-Rochard E, Roseanu A, Legrand D, Trif M, Salmon V, Motas C, Montreuil J, Spik G.

Biochem J. 1995 Dec 15;312 ( Pt 3):839-45.

43.

Expression of lactoferrin receptors is increased in the mesencephalon of patients with Parkinson disease.

Faucheux BA, Nillesse N, Damier P, Spik G, Mouatt-Prigent A, Pierce A, Leveugle B, Kubis N, Hauw JJ, Agid Y, et al.

Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9603-7.

44.

Characterization of sheep hemopexin glycovariants.

Coddeville B, Stratil A, Wieruszeski JM, Oliver RW, Green BN, Spik G.

Glycoconj J. 1995 Oct;12(5):645-50.

PMID:
8595255
45.

Human lactoferrin induces phenotypic and functional changes in murine splenic B cells.

Zimecki M, Mazurier J, Spik G, Kapp JA.

Immunology. 1995 Sep;86(1):122-7.

47.

Structural determination of two N-linked glycans isolated from recombinant human lactoferrin expressed in BHK cells.

Legrand D, Salmon V, Coddeville B, Benaissa M, Plancke Y, Spik G.

FEBS Lett. 1995 May 22;365(1):57-60.

48.

Rat mammary-gland transferrin: nucleotide sequence, phylogenetic analysis and glycan structure.

Escrivá H, Pierce A, Coddeville B, González F, Benaissa M, Léger D, Wieruszeski JM, Spik G, Pamblanco M.

Biochem J. 1995 Apr 1;307 ( Pt 1):47-55.

49.

Analysis of the N-linked oligosaccharides of human C1s using electrospray ionisation mass spectrometry.

Petillot Y, Thibault P, Thielens NM, Rossi V, Lacroix M, Coddeville B, Spik G, Schumaker VN, Gagnon J, Arlaud GJ.

FEBS Lett. 1995 Jan 30;358(3):323-8.

50.

Selective assay for CyPA and CyPB in human blood using highly specific anti-peptide antibodies.

Allain F, Boutillon C, Mariller C, Spik G.

J Immunol Methods. 1995 Jan 13;178(1):113-20.

PMID:
7829860

Supplemental Content

Support Center